Global Plasma Fractionation and Blood Product Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 23-Nov-2022
No. of pages: 113
Inquire Before Buying

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Plasma Fractionation and Blood Product is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Plasma Fractionation and Blood Product is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Plasma Fractionation and Blood Product is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Plasma Fractionation and Blood Product include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Plasma Fractionation and Blood Product manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Plasma Fractionation and Blood Product market. Further, it explains the major drivers and regional dynamics of the global Plasma Fractionation and Blood Product market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Takeda

- CSL

- Grifols

- Octapharma

- Kedrion

- LFB Group

- Biotest

- BPL

- RAAS

- CBPO

- Hualan Bio

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Plasma Fractionation and Blood Product Segment by Type

- Coagulation Factor

- Immune Globulin

- Albumin

- Other

Plasma Fractionation and Blood Product Segment by Application

- Immunology

- Hematology

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Plasma Fractionation and Blood Product market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Plasma Fractionation and Blood Product, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Plasma Fractionation and Blood Product, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Plasma Fractionation and Blood Product, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma Fractionation and Blood Product sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Plasma Fractionation and Blood Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Plasma Fractionation and Blood Product sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.

Global Plasma Fractionation and Blood Product Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Plasma Fractionation and Blood Product Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Plasma Fractionation and Blood Product Market Size (2017-2028)
2.1.1 Global Plasma Fractionation and Blood Product Revenue (2017-2028)
2.1.2 Global Plasma Fractionation and Blood Product Sales (2017-2028)
2.2 Global Plasma Fractionation and Blood Product Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Plasma Fractionation and Blood Product Sales by Regions (2017-2022)
2.2.2 Global Plasma Fractionation and Blood Product Revenue by Regions (2017-2022)
2.3 Global Plasma Fractionation and Blood Product Market Size Forecast by Region
2.3.1 Global Plasma Fractionation and Blood Product Sales Forecast by Region (2023-2028)
2.3.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Region (2023-2028)
2.4 Global Top Plasma Fractionation and Blood Product Regions (Countries) Ranking by Market Size
2.5 Plasma Fractionation and Blood Product Market Dynamics
2.5.1 Plasma Fractionation and Blood Product Market Trends
2.5.2 Plasma Fractionation and Blood Product Market Drivers
2.5.3 Plasma Fractionation and Blood Product Market Challenges
2.5.4 Plasma Fractionation and Blood Product Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Plasma Fractionation and Blood Product Manufacturers by Sales (2017-2022)
3.1.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2017-2022)
3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Plasma Fractionation and Blood Product Sales in 2021
3.2 Global Top Manufacturers Plasma Fractionation and Blood Product by Revenue
3.2.1 Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2017-2022)
3.2.2 Top Plasma Fractionation and Blood Product Manufacturers Covered: Ranking by Revenue
3.2.3 Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Plasma Fractionation and Blood Product Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2021)
3.4 Global Plasma Fractionation and Blood Product Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Plasma Fractionation and Blood Product Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Plasma Fractionation and Blood Product Market
3.7 Key Manufacturers Plasma Fractionation and Blood Product Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Plasma Fractionation and Blood Product Market Size by Type
4.1 Global Plasma Fractionation and Blood Product Historic Market Review by Type (2017-2022)
4.1.1 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
4.1.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2022)
4.1.3 Plasma Fractionation and Blood Product Price by Type (2017-2022)
4.2 Global Plasma Fractionation and Blood Product Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Plasma Fractionation and Blood Product Sales Forecast by Type (2023-2028)
4.2.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Type (2023-2028)
4.2.3 Plasma Fractionation and Blood Product Price Forecast by Type (2023-2028)
5 Global Plasma Fractionation and Blood Product Market Size by Application
5.1 Global Plasma Fractionation and Blood Product Historic Market Review by Application (2017-2022)
5.1.1 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
5.1.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2022)
5.1.3 Plasma Fractionation and Blood Product Price by Application (2017-2022)
5.2 Global Plasma Fractionation and Blood Product Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Plasma Fractionation and Blood Product Sales Forecast by Application (2023-2028)
5.2.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Application (2023-2028)
5.2.3 Plasma Fractionation and Blood Product Price Forecast by Application (2023-2028)
6 North America
6.1 North America Plasma Fractionation and Blood Product Sales Breakdown by Company
6.1.1 North America Plasma Fractionation and Blood Product Sales by Company (2017-2022)
6.1.2 North America Plasma Fractionation and Blood Product Revenue by Company (2017-2022)
6.2 North America Plasma Fractionation and Blood Product Market Size by Type
6.2.1 North America Plasma Fractionation and Blood Product Sales by Type (2017-2028)
6.2.2 North America Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
6.3 North America Plasma Fractionation and Blood Product Market Size by Application
6.3.1 North America Plasma Fractionation and Blood Product Sales by Application (2017-2028)
6.3.2 North America Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
6.4 North America Plasma Fractionation and Blood Product Market Size by Country
6.4.1 North America Plasma Fractionation and Blood Product Sales by Country (2017-2028)
6.4.2 North America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasma Fractionation and Blood Product Sales Breakdown by Company
7.1.1 Europe Plasma Fractionation and Blood Product Sales by Company (2017-2022)
7.1.2 Europe Plasma Fractionation and Blood Product Revenue by Company (2017-2022)
7.2 Europe Plasma Fractionation and Blood Product Market Size by Type
7.2.1 Europe Plasma Fractionation and Blood Product Sales by Type (2017-2028)
7.2.2 Europe Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
7.3 Europe Plasma Fractionation and Blood Product Market Size by Application
7.3.1 Europe Plasma Fractionation and Blood Product Sales by Application (2017-2028)
7.3.2 Europe Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
7.4 Europe Plasma Fractionation and Blood Product Market Size by Country
7.4.1 Europe Plasma Fractionation and Blood Product Sales by Country (2017-2028)
7.4.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Plasma Fractionation and Blood Product Sales Breakdown by Company
8.1.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Company (2017-2022)
8.1.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Company (2017-2022)
8.2 Asia Pacific Plasma Fractionation and Blood Product Market Size by Type
8.2.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2028)
8.2.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
8.3 Asia Pacific Plasma Fractionation and Blood Product Market Size by Application
8.3.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2028)
8.3.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
8.4 Asia Pacific Plasma Fractionation and Blood Product Market Size by Region
8.4.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Region
8.4.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Plasma Fractionation and Blood Product Sales Breakdown by Company
9.1.1 Latin America Plasma Fractionation and Blood Product Sales by Company (2017-2022)
9.1.2 Latin America Plasma Fractionation and Blood Product Revenue by Company (2017-2022)
9.2 Latin America Plasma Fractionation and Blood Product Market Size by Type
9.2.1 Latin America Plasma Fractionation and Blood Product Sales by Type (2017-2028)
9.2.2 Latin America Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
9.3 Latin America Plasma Fractionation and Blood Product Market Size by Application
9.3.1 Latin America Plasma Fractionation and Blood Product Sales by Application (2017-2028)
9.3.2 Latin America Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
9.4 Latin America Plasma Fractionation and Blood Product Market Size by Country
9.4.1 Latin America Plasma Fractionation and Blood Product Sales by Country (2017-2028)
9.4.2 Latin America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Plasma Fractionation and Blood Product Sales Breakdown by Company
10.1.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Company (2017-2022)
10.1.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Company (2017-2022)
10.2 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Type
10.2.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2017-2028)
10.2.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
10.3 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Application
10.3.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2017-2028)
10.3.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
10.4 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country
10.4.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2017-2028)
10.4.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Takeda Plasma Fractionation and Blood Product Products and Services
11.1.5 Takeda Plasma Fractionation and Blood Product SWOT Analysis
11.1.6 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 CSL Plasma Fractionation and Blood Product Products and Services
11.2.5 CSL Plasma Fractionation and Blood Product SWOT Analysis
11.2.6 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Grifols Plasma Fractionation and Blood Product Products and Services
11.3.5 Grifols Plasma Fractionation and Blood Product SWOT Analysis
11.3.6 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Octapharma Plasma Fractionation and Blood Product Products and Services
11.4.5 Octapharma Plasma Fractionation and Blood Product SWOT Analysis
11.4.6 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Corporation Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Kedrion Plasma Fractionation and Blood Product Products and Services
11.5.5 Kedrion Plasma Fractionation and Blood Product SWOT Analysis
11.5.6 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Corporation Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 LFB Group Plasma Fractionation and Blood Product Products and Services
11.6.5 LFB Group Plasma Fractionation and Blood Product SWOT Analysis
11.6.6 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Corporation Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Biotest Plasma Fractionation and Blood Product Products and Services
11.7.5 Biotest Plasma Fractionation and Blood Product SWOT Analysis
11.7.6 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Corporation Information
11.8.2 BPL Overview
11.8.3 BPL Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 BPL Plasma Fractionation and Blood Product Products and Services
11.8.5 BPL Plasma Fractionation and Blood Product SWOT Analysis
11.8.6 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Corporation Information
11.9.2 RAAS Overview
11.9.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 RAAS Plasma Fractionation and Blood Product Products and Services
11.9.5 RAAS Plasma Fractionation and Blood Product SWOT Analysis
11.9.6 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Overview
11.10.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 CBPO Plasma Fractionation and Blood Product Products and Services
11.10.5 CBPO Plasma Fractionation and Blood Product SWOT Analysis
11.10.6 CBPO Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Corporation Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Hualan Bio Plasma Fractionation and Blood Product Products and Services
11.11.5 Hualan Bio Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Plasma Fractionation and Blood Product Value Chain Analysis
12.2 Plasma Fractionation and Blood Product Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Fractionation and Blood Product Production Mode & Process
12.4 Plasma Fractionation and Blood Product Sales and Marketing
12.4.1 Plasma Fractionation and Blood Product Sales Channels
12.4.2 Plasma Fractionation and Blood Product Distributors
12.5 Plasma Fractionation and Blood Product Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Other
Table 6. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Plasma Fractionation and Blood Product Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 9. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2022)
Table 10. Global Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2022)
Table 12. Global Plasma Fractionation and Blood Product Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Plasma Fractionation and Blood Product Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Plasma Fractionation and Blood Product Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Plasma Fractionation and Blood Product Market Trends
Table 18. Plasma Fractionation and Blood Product Market Drivers
Table 19. Plasma Fractionation and Blood Product Market Challenges
Table 20. Plasma Fractionation and Blood Product Market Restraints
Table 21. Global Plasma Fractionation and Blood Product Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Plasma Fractionation and Blood Product Sales Share by Manufacturers (2017-2022)
Table 23. Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Plasma Fractionation and Blood Product Manufacturers by Revenue (US$ Million) in 2021
Table 25. Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2017-2022)
Table 26. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2021)
Table 28. Key Manufacturers Plasma Fractionation and Blood Product Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 29. Key Manufacturers Plasma Fractionation and Blood Product Plants/Factories Distribution
Table 30. Key Manufacturers Plasma Fractionation and Blood Product Area Served
Table 31. Date of Key Manufacturers Enter into Plasma Fractionation and Blood Product Market
Table 32. Key Manufacturers Plasma Fractionation and Blood Product Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Plasma Fractionation and Blood Product Sales (K Units) by Type (2017-2022)
Table 35. Global Plasma Fractionation and Blood Product Sales Share by Type (2017-2022)
Table 36. Global Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Plasma Fractionation and Blood Product Price (K Units) by Type (2017-2022)
Table 38. Global Plasma Fractionation and Blood Product Sales (K Units) by Type (2023-2028)
Table 39. Global Plasma Fractionation and Blood Product Sales Share by Type (2023-2028)
Table 40. Global Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Plasma Fractionation and Blood Product Revenue Share by Type (2023-2028)
Table 42. Global Plasma Fractionation and Blood Product Price (K Units) by Type (2023-2028)
Table 43. Global Plasma Fractionation and Blood Product Sales (K Units) by Application (2017-2022)
Table 44. Global Plasma Fractionation and Blood Product Sales Share by Application (2017-2022)
Table 45. Global Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Plasma Fractionation and Blood Product Price (K Units) by Application (2017-2022)
Table 47. Global Plasma Fractionation and Blood Product Sales (K Units) by Application (2023-2028)
Table 48. Global Plasma Fractionation and Blood Product Sales Share by Application (2023-2028)
Table 49. Global Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Plasma Fractionation and Blood Product Revenue Share by Application (2023-2028)
Table 51. Global Plasma Fractionation and Blood Product Price (K Units) by Application (2023-2028)
Table 52. North America Plasma Fractionation and Blood Product Sales by Company (2017-2022) & (K Units)
Table 53. North America Plasma Fractionation and Blood Product Sales Market Share by Company (2017-2022)
Table 54. North America Plasma Fractionation and Blood Product Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Plasma Fractionation and Blood Product Revenue Market Share by Company (2017-2022)
Table 56. North America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 57. North America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 58. North America Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 61. North America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 62. North America Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 65. North America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 66. North America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Plasma Fractionation and Blood Product Sales by Company (2017-2022) & (K Units)
Table 69. Europe Plasma Fractionation and Blood Product Sales Market Share by Company (2017-2022)
Table 70. Europe Plasma Fractionation and Blood Product Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Plasma Fractionation and Blood Product Revenue Market Share by Company (2017-2022)
Table 72. Europe Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 73. Europe Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 74. Europe Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 77. Europe Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 78. Europe Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 81. Europe Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 82. Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Plasma Fractionation and Blood Product Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Plasma Fractionation and Blood Product Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Plasma Fractionation and Blood Product Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Plasma Fractionation and Blood Product Sales Market Share by Company (2017-2022)
Table 102. Latin America Plasma Fractionation and Blood Product Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Plasma Fractionation and Blood Product Revenue Market Share by Company (2017-2022)
Table 104. Latin America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Plasma Fractionation and Blood Product Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 132. Takeda Corporation Information
Table 133. Takeda Description and Overview
Table 134. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 135. Takeda Plasma Fractionation and Blood Product Product and Services
Table 136. Takeda Plasma Fractionation and Blood Product SWOT Analysis
Table 137. Takeda Recent Developments
Table 138. CSL Corporation Information
Table 139. CSL Description and Overview
Table 140. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 141. CSL Plasma Fractionation and Blood Product Product and Services
Table 142. CSL Plasma Fractionation and Blood Product SWOT Analysis
Table 143. CSL Recent Developments
Table 144. Grifols Corporation Information
Table 145. Grifols Description and Overview
Table 146. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 147. Grifols Plasma Fractionation and Blood Product Product and Services
Table 148. Grifols Plasma Fractionation and Blood Product SWOT Analysis
Table 149. Grifols Recent Developments
Table 150. Octapharma Corporation Information
Table 151. Octapharma Description and Overview
Table 152. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
  • Global Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 108
    The immunoglobulin combination was separated and extracted from normal human plasma by the low-temperature ethanol method, and refined through further processing and virus inactivation steps. This product is a complete, unmodified natural lgG antibody with a purity of up to 98%. It contains no preservatives and antibiotics and is intended for intravenous infusion. Compared with intramuscular gamma globulin, it has a faster effect and a significant effect. advantage. Report Overview ......
  • Global Albendazole Veterinary Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 139
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Albendazole Veterinary Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China mar......
  • Global Measles, Mumps and Rubella (MMR) Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 115
    Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects. Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAG......
  • Global Human Recombinant Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 114
    Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.Recombinant human insulin has a significant advantage over insulin from other animal sources. Patients can better absorb human insulin.It is also easier to manage allergies related to insulin intake. Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Inf......
  • Global High Potency APIs (HPAPI) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 125
    HPAPI is a very effective pharmacological active ingredient.Their effects are highly specific, providing significant efficiencies even at low daily therapeutic doses. Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for High Potency A......
  • Global Fibromyalgia Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 126
    Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors). Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product N......
  • Global Benign Prostatic Hyperplasia (BPH) Medication Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 132
    BPH (benign prostatic hyperplasia, BPH) is a common disease and frequently encountered disease in older men, main show is prostate of glands and stroma hyperplasia, prostate enlargement, lower urinary tract symptoms (the lower urinary tract symptom, LUTS), and bladder outlet obstruction.There are currently three major classes of drugs for BPH: 5-beta-reductase inhibitors, such as finasteride;Beta-blockers, such as terazosin hydrochloride, doxazosin mesylate, etc.Herbal preparations and Chinese m......
  • Global Antispasmodic and Anticholinergic H2 Blocking Agents Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 117
    The antispasmodics and anticholinergic are a group of medicines such as natural belladonna alkaloids which contains belladonna,atropine, scopolamine, hyoscyamine and other drugs and include natural,semisynthetic derivatives,synthetic compounds . The antispasmodics and anticholinergic are generally used to relieve crampsand spasms of the intestine, stomach, and bladder. These drugs are used in the combination with antacids and other medicines forthe treatment of ulcers, vomiting, nausea and motio......
  • Global Orthopedics Joint Cavity Viscoelastic Supplement Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Dec-2022        Price: US 5600 Onwards        Pages: 101
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Orthopedics Joint Cavity Viscoelastic Supplement is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs